Cargando…

Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: A retrospective analysis

BACKGROUND & OBJECTIVES: Advanced epithelial ovarian cancer (EOC) is associated with dismal outcome and progression-free survival (PFS) shortens with each subsequent relapse. For patients with recurrent and platinum refractory disease, therapeutic options are limited. Oral metronomic therapy (OM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Aparna, Malik, Prabhat Singh, Khurana, Sachin, Kumar, Sunesh, Bhatla, Neerja, Ray, M.D., Kumar, Lalit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038810/ https://www.ncbi.nlm.nih.gov/pubmed/32048620 http://dx.doi.org/10.4103/ijmr.IJMR_2030_18

Ejemplares similares

Early-Stage epithelial ovarian cancer: Predictors of survival
por: Upadhyay, Avinash, et al.
Publicado: (2022)

Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia
por: Singhal, Seema, et al.
Publicado: (2020)

Oncologic and reproductive outcomes of borderline ovarian tumors in Indian population
por: Kumari, Sarita, et al.
Publicado: (2021)

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019)

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019)

Prognostic Significance of HE4 Tissue Expression in Serous Epithelial Ovarian Carcinoma
por: Sethi, Ankita, et al.
Publicado: (2022)

Radiological evaluation of metastatic lymph nodes in carcinoma cervix with emphasis on their infiltrative pattern
por: Dhamija, Ekta, et al.
Publicado: (2021)

Expression of DKK1 in Endometrial Endometrioid Carcinoma and Its Correlation with Wnt/β-catenin Signalling Pathway
por: Das, Abhijit, et al.
Publicado: (2023)

High-dose-rate interstitial brachytherapy for female peri-urethral cancer
por: Sharma, Daya Nand, et al.
Publicado: (2016)

Metronomic palliative chemotherapy in maxillary sinus tumor
por: Patil, Vijay M., et al.
Publicado: (2016)

Metronomic chemotherapy
por: Maiti, Rituparna
Publicado: (2014)

Metronomic Chemotherapy
por: Cazzaniga, Marina Elena, et al.
Publicado: (2021)

Effectiveness and toxicity of metronomic oral cyclophosphamide for recurrent or platinum-refractory ovarian cancer: A meta-analysis
por: Huang, Lili, et al.
Publicado: (2022)

Imaging in Carcinoma Cervix and Revised 2018 FIGO Staging System: Implications in Radiology Reporting
por: Dhamija, Ekta, et al.
Publicado: (2021)

Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer
por: Samaritani, Riccardo, et al.
Publicado: (2007)

A Cross-Sectional Analysis to Evaluate Knowledge, Attitude And Practices Among Pregnant Women During COVID-19 Pandemic
por: Kaur, Tarang P., et al.
Publicado: (2021)

Nanoformulations-Based Metronomic Chemotherapy: Mechanism, Challenges, Recent Advances, and Future Perspectives
por: Panthi, Vijay Kumar, et al.
Publicado: (2023)

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman Andrés, et al.
Publicado: (2017)

Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer
por: Babanrao Dhumal, Sachin, et al.
Publicado: (2023)

Outcomes of advanced epithelial ovarian cancer with integration of metronomic chemotherapy: An Indian rural cancer centre experience
por: Pandey, Avinash, et al.
Publicado: (2016)

Excellent response to oral Metronomic chemotherapy in unresectable adenocarcinoma of external auditory canal
por: Noronha, Vanita, et al.
Publicado: (2015)

Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy
por: Khandakar, Binny, et al.
Publicado: (2014)

Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch
por: Malik, Prabhat Singh, et al.
Publicado: (2014)

Metronomic Chemotherapy in Prostate Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2022)

Metronomic chemotherapy in platinum-insensitive failures and/or early failures postmultimodality management in oral cancers
por: Patil, Vijay M., et al.
Publicado: (2015)

Feasibility of metronomic chemotherapy with tegafur-uracil, cisplatin, and dexamethasone for docetaxel-refractory prostate cancer
por: Kubota, Hiroki, et al.
Publicado: (2017)

Dehydroepiandrosterone as an adjunct to gonadotropins in infertile Indian women with premature ovarian aging: A pilot study
por: Malik, Nisha, et al.
Publicado: (2015)

Long-term adjuvant metronomic chemotherapy in a dog with recurrent maxillofacial osteosarcoma
por: Jung, Min-Jung, et al.
Publicado: (2023)

Head and neck cancer: metronomic chemotherapy
por: De Felice, Francesca, et al.
Publicado: (2015)

Metastatic Primary Angiosarcoma of the Breast: Can We Tame It the Metronomic Way
por: Pramanik, Raja, et al.
Publicado: (2017)

Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
por: Maharjan, Ruby, et al.
Publicado: (2019)

Next generation metronomic chemotherapy—report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6–8 May 2016, Mumbai
por: Pantziarka, Pan, et al.
Publicado: (2016)

Metronomic chemotherapy: changing the paradigm that more is better
por: Scharovsky, O.G., et al.
Publicado: (2009)

Response assessment in metronomic chemotherapy: RECIST or PERCIST?
por: Agrawal, Archi, et al.
Publicado: (2014)

Metronomic chemotherapy for triple negative breast cancer?
por: Di Desidero, Teresa, et al.
Publicado: (2016)

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer
por: Noronha, Vanita, et al.
Publicado: (2016)

Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists
por: Revon-Rivière, Gabriel, et al.
Publicado: (2019)

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2023)

Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases
por: Isono-Nakata, Rose, et al.
Publicado: (2018)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ggjmclj8oqi4fn3fg0q1ekqdds